Table 1 Tailored immunosuppressive regimens in the Zurich renal transplant program before 2006 and from 2008 to 2011
From: Tailored immunosuppression after kidney transplantation - a single center real-life experience
Regimen | Patient group | Transplantation until 2006 | Transplantation from 2008 |
|---|---|---|---|
1 | first transplantation without anti-HLA immunization | cyclosporine, MMF, prednisone | cyclosporine, MMF, prednisone |
2a | retransplantation and/or anti-HLA immunization, but without DSA | basiliximab, tacrolimus, MMF, prednisone | basiliximab, tacrolimus, MMF, prednisone |
2b | recipient with DSA and negative CDC cross-match | basiliximab, tacrolimus, MMF, prednisone | thymoglobulin, tacrolimus, MMF, prednisone |
3 | donor risk (age above 75, cold ischemia time > 24 h, DCD) | thymoglobulin, tacrolimus delayed (day 5), MMF, prednisone | thymoglobulin, tacrolimus delayed (day 5), MMF, prednisone |
4 | ABO blood group incompatibility | (not performed) | rituximab + IADS, tacrolimus, MMF, prednisone |